Last week Aleksandr Stiblo, GCT Deputy Director Business Development, participated at the VIII International forum “Life Sciences Invest. Partnering Russia” in St. Petersburg, Russia.
It is a great opportunity to enhance the business contacts of companies and investors within life sciences industry in Russia. The Forum aims at supporting current federal initiatives to develop the pharmaceutical market as one of the key areas that provide a comfortable life and stability, creating the basis for a dynamic economic growth of the country.
Thanks to its biggest population in Europe and high qualification of investigators, Russia has a great potential for clinical trials. FDA and EMEA inspections confirm the high quality of clinical data. The government continues to reduce administrative barriers and simplify registration procedures in the Russian Federation.
GCT has 17 years of experience on the clinical trials market in Russia in different phases and indications. To discuss potential project, please write to bd@gctrials.com.